|
|
||||||||
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
The anaphylatoxin C3a has been reported to have immunomodulatory
effects on a number of different cell types. In this study we
investigated the effects of C3a and C3adesArg on gene
expression and protein secretion of IL-6 in human PBMCs, either alone
or in combination with LPS or IL-1ß. C3a or C3adesArg
alone exhibited no effect on the expression or secretion of IL-6.
However, when PBMC were stimulated with LPS or IL-1ß, both C3a and
C3adesArg were found to enhance IL-6 release by PBMC in a
dose-dependent manner. Since C3a has been shown to induce
PGE2 production by monocytes, and PGE2 has been
shown to influence cytokine production, we investigated the potential
role of PGE2 in C3a-mediated enhancement of LPS- and
IL-1ß-induced IL-6 production. Indomethacin blocked PGE2
release, but had no influence on the observed effects of C3a,
suggesting that the effects of C3a on IL-6 production are independent
of PGE2 formation by monocytes. Northern blot analysis
showed that C3a as well as C3adesArg enhanced LPS-induced
mRNA levels for IL-6. Pretreatment of PBMCs with pertussis toxin
blocked the functions of C3a and C3adesArg, indicating that
the actions of these two molecules are mediated by a G protein-coupled
pathway. Furthermore, we investigated the effects of C3a and
C3adesArg on induction of NF-
B and activating protein-1
binding. Both molecules enhanced LPS-induced NF-
B and activating
protein-1 binding activity. These results demonstrate the capacity of
intact C3a and its circulating des-Arg form to exert immunmodulatory
effects in vitro.
This article has been cited by other articles:
![]() |
M. M. Markiewski and J. D. Lambris The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight Am. J. Pathol., September 1, 2007; 171(3): 715 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Purwar, M. Wittmann, J. Zwirner, M. Oppermann, M. Kracht, O. Dittrich-Breiholz, R. Gutzmer, and T. Werfel Induction of C3 and CCL2 by C3a in Keratinocytes: A Novel Autocrine Amplification Loop of Inflammatory Skin Reactions J. Immunol., October 1, 2006; 177(7): 4444 - 4450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ritis, M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J. D. Lambris A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways J. Immunol., October 1, 2006; 177(7): 4794 - 4802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Mueller-Ortiz, T. J. Hollmann, D. L. Haviland, and R. A. Wetsel Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L157 - L165. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kalant, R. MacLaren, W. Cui, R. Samanta, P. N. Monk, S. A. Laporte, and K. Cianflone C5L2 Is a Functional Receptor for Acylation-stimulating Protein J. Biol. Chem., June 24, 2005; 280(25): 23936 - 23944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Boos, I. L. Campbell, R. Ames, R. A. Wetsel, and S. R. Barnum Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis J. Immunol., October 1, 2004; 173(7): 4708 - 4714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Recinos III, B. K. Carr, D. B. Bartos, I. Boldogh, J. R. Carmical, L. M. Belalcazar, and A. R. Brasier Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway Physiol Genomics, September 16, 2004; 19(1): 131 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Strey, M. Markiewski, D. Mastellos, R. Tudoran, L. A. Spruce, L. E. Greenbaum, and J. D. Lambris The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration J. Exp. Med., September 15, 2003; 198(6): 913 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Inal, B. Schneider, M. Armanini, and J. A. Schifferli A Peptide Derived from the Parasite Receptor, Complement C2 Receptor Inhibitor Trispanning, Suppresses Immune Complex-Mediated Inflammation in Mice J. Immunol., April 15, 2003; 170(8): 4310 - 4317. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Monari, T. R. Kozel, F. Bistoni, and A. Vecchiarelli Modulation of C5aR Expression on Human Neutrophils by Encapsulated and Acapsular Cryptococcus neoformans Infect. Immun., July 1, 2002; 70(7): 3363 - 3370. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma J. Immunol., February 1, 2001; 166(3): 2025 - 2032. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |